Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab

Idiopathic hypereosinophilic syndrome (IHES) is a rare disease characterized by causeless persistent hypereosinophilia and eosinophilia-associated end-organ damage. Current treatment modalities don’t meet the needs due to adverse events of steroids as first-line therapy and the limited efficacy of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhiyu, Sun, Yingxin, Chen, Su-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285082/
https://www.ncbi.nlm.nih.gov/pubmed/37361219
http://dx.doi.org/10.3389/fphar.2023.1095737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285082/
https://www.ncbi.nlm.nih.gov/pubmed/37361219
http://dx.doi.org/10.3389/fphar.2023.1095737

Ejemplares similares